Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash $ 9,485 $ 9,299
Total current assets: 9,485 9,299
Total assets 9,485 9,299
Current liabilities:    
Accounts payable 419,859 407,913
Accrued interest payable 34,763 28,770
Note payable, net of debt discount $1,517 and $1,517, respectively 145,483 145,483
Note payable - related parties 16,000 16,000
Convertible note payable 121,000 121,000
Fair value of derivative liability - beneficial conversion feature 46,476 38,756
Deposit 132,971
Total current liabilities 783,581 890,893
Total liabilities 783,581 890,893
Stockholders' deficit:    
Preferred stock authorized 25,000,000 shares, $.0001 par value, no shares issued and outstanding at March 31, 2017 and December 31, 2016.
Common stock authorized 100,000,000 shares, $.0001 par value, 51,411,443 shares issued and outstanding at March 31, 2017 and December 31, 2016. 5,141 5,141
Additional paid-in capital 4,223,728 4,175,170
Accumulated deficit (5,002,965) (5,061,905)
Total stockholders' deficit (774,096) (881,594)
Total liabilities and stockholders' deficit $ 9,485 $ 9,299